PriceMDs has launched a smart new Treatment Cost Containment Solution that is designed specifically for individual employees and plan members suffering from conditions such as hemophilia, rheumatoid arthritis, colitis, psoriasis, Crohn’s disease, multiple sclerosis and more. Treatments for these conditions can be very expensive and costly with frightening potential complications for any employer bottom line. Now, PriceMDs offers an all-inclusive Treatment Cost Containment Solution that reduces the total treatment cost to employers, patients and plans by up to 70% below the standard cost. Treating any high cost hemophilia condition for example, can save hundreds of thousands of dollars per patient annually. In other, much more common treatments, savings of as much as $50,000 — $75,000 per year can also be realized.
All treatments are administered in high quality, accredited medical facilities in the Cayman Islands and in health centres in the Bahamas. PriceMDs has contracted and has locked-in discounted service rates to obtain all the correct information and to expedite all travel documents at a pre-negotiated discounted rate. These arrangements have been extensively vetted by PriceMDs’ principal law firm, Greenberg Traurig, P.A..
Our Treatment Cost Containment is a regulatory compliant solution for providing high cost specialty pharmaceuticals at greatly reduced prices inclusive of all travel to our participating, international medical facilities.